Bioptimus

Key milestones that highlight the impact and adoption of our foundation models across the scientific community

Bioptimus builds a foundation model for biology, training AI systems across multiple biological scales and data types to help predict how diseases and treatments behave. Rather than analyzing cells, tissues, and organs in separate silos, its models learn jointly across these scales, aiming to explain why patients with similar clinical profiles can respond differently to the same drug.

Its platform includes H-Optimus and M-Optimus, plus an initiative called STELA that generates deeply profiled, clinically linked, multimodal patient data across geographies and diseases, since the biological data needed to train these models often does not exist yet at the scale required. As a research tool in the Research category, it is used by pharmaceutical and life-science institutions working on drug discovery, biomedicine, and clinical trials, and the site states it is trusted by a majority of the top twenty pharma companies and more than a thousand institutions worldwide.

No specific pricing plan is described in the available material, so the payment model cannot be confirmed from the site. Explore Bioptimus's models and research to see how its foundation-model approach applies to a specific biology or biomedicine problem.

Category: Research. Pricing: freemium. Visit website

Alternatives to Bioptimus in Research

• Yila AI — Evidence-traceable research agent for literature review, PDF analysis, figures, and academic slides.
• Deep Search — AI web research, chat and public-information lookups
• ScholarIQ — ScholarIQ searches 470M+ articles from OpenAlex, ORCID and PubMed — and answers in plain language, with every claim cit…
• Tracetify — Evidence-led competitor launch intelligence for founders and marketers.
• XLeadForge — X outbound, queued daily in your voice
• Reverse Image Location — AI image geolocation and visual clue analysis